Entrapment efficiency is strongly shaped by how the carrier and active compound interact during formulation. Carrier composition can determine how much cargo is retained, while drug properties affect compatibility with the carrier. Solvent selection, mixing conditions, and particle-formation conditions further influence retention. Comparing formulations under controlled preparation conditions helps identify which design variables improve cargo incorporation.
Solvent selection and mixing are not merely processing details: they can alter how the active compound becomes associated with the forming carrier. Particle formation then influences whether that material remains within the resulting particles or vesicles. Changes at these stages may increase or decrease the retained fraction, so optimization should evaluate the complete preparation sequence rather than changing carrier composition alone.
Entrapment efficiency should not be interpreted in isolation. Loading capacity, release behavior, and stability provide complementary information about formulation performance. Considering these measures together gives a more complete assessment than relying on a single percentage, because a carrier may retain cargo while still requiring evaluation of how much it contains, how it releases that cargo, and whether its performance remains consistent.
Measurement begins by separating unencapsulated active material from the loaded particles or vesicles. The amount retained in the carrier is then compared with the total amount used during formulation, and the result is expressed as a percentage. This separation step is central because incomplete removal of free compound can make the formulation appear to retain more cargo than it actually does.
Researchers can use the measurement to compare alternative carrier compositions, drug properties, solvents, mixing conditions, or particle-formation conditions. A formulation that retains a larger fraction of the starting cargo may offer greater transport potential, but the value should be reviewed alongside loading capacity, release behavior, and stability. This combined assessment helps avoid optimizing one metric at the expense of overall platform performance.
In bioengineered carriers, the measurement links preparation conditions with the amount of active cargo available for transport. It supports evaluation of particles or vesicles designed to carry therapeutic compounds and helps researchers judge formulation consistency across candidate systems. Because delivery platforms must also be assessed for release and stability, entrapment efficiency contributes to, rather than replaces, broader performance evaluation.